(+/-)-N-3-Benzylnirvanol manufacturers
|
| | (+/-)-N-3-Benzylnirvanol Basic information |
| | (+/-)-N-3-Benzylnirvanol Chemical Properties |
| Melting point | 134-136°C | | density | 1.190±0.06 g/cm3(Predicted) | | storage temp. | -20°C Freezer | | solubility | DMSO (Slightly), Methanol (Slightly) | | pka | 8.02±0.70(Predicted) | | form | Solid | | color | White to Off-White |
| | (+/-)-N-3-Benzylnirvanol Usage And Synthesis |
| Description | (±)-N-3-Benzylnirvanol is a racemic mixture of (+)-N-3-benzylnirvanol and (–)-N-3-benzylnirvanol. (+)-N-3-benzylnirvanol and (–)-N-3-benzylnirvanol are inhibitors of the cytochrome P450 (CYP) isoform CYP2C19 (Kis = 0.25 and 5.3 μM, respectively). (±)-N-3-Benzylnirvanol (20 mg/kg, i.p.) lowers plasma levels of cholesterol in mice. | | Chemical Properties | White Solid | | Uses | It is a potent and selective human CYP2C19 inhibitor | | References | [1] HISASHI SUZUKI. (+)-N-3-Benzyl-nirvanol and (-)-N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19.[J]. Drug Metabolism and Disposition, 2002, 23 1: 235-239. DOI: 10.1124/dmd.30.3.235 [2] JAMES H. MAGUIRE Iris H H Akula R Murthy. Hypolipidemic activity of antiepileptic 5-phenylhydantoins in mice[J]. European journal of pharmacology, 1985, 117 1: Pages 135-138. DOI: 10.1016/0014-2999(85)90483-2 |
| | (+/-)-N-3-Benzylnirvanol Preparation Products And Raw materials |
|